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Fig 1. Total mastectomy of the right breast revealed Paget
disease with underlying foci of ductal carcinoma in situ
(shown above). (Hematoxylin-eosin stain; original magni-
fication: 3100.)
Fig 2. In the axilla, atypical large cells with prominent
nuclei and pale cytoplasm are present diffusely within the
epidermis. (Hematoxylin-eosin stain; original magnifica-
tion: 3200.)
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Synchronous Paget disease of the breast and
axilla
To the Editor: Mammary Paget disease (MPD) and
extramammary Paget disease (EMPD) are rare
acquired skin disorders having clinical features that
are similar to those of inflammatory or infectious skin
disorders. MPD is mostly associated with high-grade
ductal carcinoma in situ, whereas EMPD arises in
areas rich in apocrine glands. EMPD is classified into
primary and secondary EMPD; the latter is associated
with underlying malignancy and may arise as a result
of epidermal invasion of malignant adenocarcinoma
cells.
We report a rare case of synchronous Paget
disease. A 63-year-old woman presented concom-
itantly with crusting and erosion of the right nipple,
with brown plaques on the left axilla. Breast lesion
biopsy specimen indicated underlying foci of ductal
carcinoma in situ, which required total mastectomy
and sentinel lymph node biopsy. Axilla biopsy
specimen indicated EMPD, which required simpleOpen access under CC BY-NC-ND license.resection of the left axilla lesion. Both tumors were
located in the epithelium (Figs 1 and 2), and axillary
sentinel lymph node biopsy specimen yielded
negative results. Because the operative margins
were negative and both tumors were staged as
TisN0M0, the treatment was deemed adequate.
Gross cystic disease fluid protein-15 and estrogen
receptor were expressed in the breast, but not in the
axilla tumor cells. Immunohistochemical and path-
ological analyses indicated that neither of these
were secondary metastatic lesions, but suggested
that they arose from independent tumorigenic
events.
Cases of synchronous MPD and EMPD are
extremely rare; to our knowledge, only 2 other cases
have been reported. This report is the first to
our knowledge that describes the simultaneous
diagnosis of synchronous Paget disease of the breast
and axilla.
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Letters e45The origin of MPD and EMPD is controversial; it
may reportedly involve the intraepithelial epidermo-
tropic migration of carcinoma cells to the epidermis,
followed by in situ neoplastic transformation of
multipotential cells located in the basallayer of the
lactiferous duct and epidermis.1 Schelfhout et al2
reported that heregulin-, a motility factor released
by nipple keratinocytes, plays a key role in the
spread of Paget cells throughout the nipple
epidermis. A recent study hypothesized that Toker
cells, which are intraepithelial cells with a paler
cytoplasm than surrounding keratinocytes, are
precursors of MPD3 and EMPD.4
In our case, the development of synchronous
Paget disease can be explained by the pathogenetic
multicentric theory5ea unified explanation of
synchronous lesions in the vulva and axilla, and
multiple lesions within a single aspect, occurring by
the same mechanism. In frequently affected sites of
Paget disease (eg, vulva, anus, axilla), the entire
aspect assumes a ‘‘cancer readiness state.’’ However,
it is more easily explained as some oncogenic
stimulus that results in synchronous, heterochronic,
and multicentric oncogenesis. First, an oncogenic
stimulus elicits in situ transformation of Toker cells,
after which heregulin- induces chemotaxis of
carcinoma cells; these carcinoma cells eventually
migrate via the lactipherous ducts into the right
nipple epidermis. A similar process may explain
the initiation and spread of cutaneous EMPD in the
axilla. However, based on the immunohistochemical
differences, we infer that each lesion arose from
distinct types of as-yet-uncharacterized Toker cells.
Further study can help develop effective therapeutic
strategies, particularly in patients with recurrent
EMPD.Keiju Kobayashi, MD,a Yasuyuki Sumikawa, MD,
PhD,a Yumiko Kikuchi, MD,a Yuji Kan, MD,
PhD,a Junji Kato, MD,a Fukino Satomi, MD,b
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